U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
CITATUZUMAB BOGATOX
INN   WHO-DD  
INN  
Official Name English
VB6-845
Preferred Name English
ANTI-EPCAM ANTIBODY FRAGMENT-BOUGANIN FUSION PROTEIN
Common Name English
Citatuzumab bogatox [WHO-DD]
Common Name English
citatuzumab bogatox [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C575
Created by admin on Mon Mar 31 20:38:06 GMT 2025 , Edited by admin on Mon Mar 31 20:38:06 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C71694
Created by admin on Mon Mar 31 20:38:06 GMT 2025 , Edited by admin on Mon Mar 31 20:38:06 GMT 2025
PRIMARY
INN
9046
Created by admin on Mon Mar 31 20:38:06 GMT 2025 , Edited by admin on Mon Mar 31 20:38:06 GMT 2025
PRIMARY
ChEMBL
CHEMBL1743000
Created by admin on Mon Mar 31 20:38:06 GMT 2025 , Edited by admin on Mon Mar 31 20:38:06 GMT 2025
PRIMARY
SMS_ID
300000025297
Created by admin on Mon Mar 31 20:38:06 GMT 2025 , Edited by admin on Mon Mar 31 20:38:06 GMT 2025
PRIMARY
CAS
945228-49-9
Created by admin on Mon Mar 31 20:38:06 GMT 2025 , Edited by admin on Mon Mar 31 20:38:06 GMT 2025
PRIMARY
WIKIPEDIA
CITATUZUMAB BOGATOX
Created by admin on Mon Mar 31 20:38:06 GMT 2025 , Edited by admin on Mon Mar 31 20:38:06 GMT 2025
PRIMARY
FDA UNII
23J303Z5CA
Created by admin on Mon Mar 31 20:38:06 GMT 2025 , Edited by admin on Mon Mar 31 20:38:06 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966